World Renowned Cancer Physician and Researcher Philip Philip, M.D., Ph.D., Joins Henry Ford Cancer Institute
The medical oncologist has led many breakthroughs in pancreatic cancer, neuroendocrine tumors
DETROIT (Jan. 6, 2022) – Internationally renowned medical oncologist Philip A. Philip, M.D., Ph.D., has joined Henry Ford Cancer Institute (HFCI) as director of Gastrointestinal Oncology and Neuroendocrine Oncology, medical director of Research and Clinical Care Integration, and co-leader of the Henry Ford Pancreatic Cancer Center (HFPCC). Joining Henry Ford’s team of leading cancer experts, Dr. Philip has led numerous breakthroughs over the course of his career in the areas of pancreatic cancer and neuroendocrine tumors.
“Dr. Philip is a prolific researcher and skillful clinician with extensive experience in an academic medical center environment,” said Steven Kalkanis, M.D., CEO of the Henry Ford Medical Group and Chief Academic Officer at Henry Ford Health System. “He is a strong leader with a proven track record demonstrating his deep commitment to providing outstanding patient care and achieving scientific breakthroughs that are continuing to help advance research in many aspects of pancreatic cancer. We are thrilled to have Dr. Philip joining our Henry Ford Cancer Institute as we launch into the next generation of both patient care and clinical research.”